These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4043871)

  • 1. [Pharmacological effects of CM6912 and its main metabolites].
    Morishita H; Kushiku K; Furukawa T; Yamaki Y; Izawa M; Shibazaki Y; Shibata U
    Nihon Yakurigaku Zasshi; 1985 Jul; 86(1):71-85. PubMed ID: 4043871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of the antianxiety compound suriclone and its principal metabolites.
    Morishita H; Kushiku K; Matsuki J; Tokunaga T; Inoue T; Mori R; Kawamoto H; Furukawa T
    Arzneimittelforschung; 1987 Dec; 37(12):1332-40. PubMed ID: 2896505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect on 3H-diazepam binding and potentiating action on GABA of ethyl loflazepate, a new minor tranquilizer.
    Sakai Y; Namima M
    Jpn J Pharmacol; 1985 Apr; 37(4):373-9. PubMed ID: 2861304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of the sleep inducer zopiclone.
    Tokunaga T; Morishita H; Kushiku K; Abe M; Matsuki J; Inoue T; Kawamoto H; Furukawa T
    Arzneimittelforschung; 1987 Dec; 37(12):1340-5. PubMed ID: 3449060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
    Kito G; Morimoto S; Shiomi M
    Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological studies of a new sleep-inducer, 1H-1,2,4-triazolyl benzophenone derivative (450191-S) (V). General pharmacological activities].
    Yamamoto K; Ueda M; Kurosawa A; Hirose K; Doteuchi M; Nakamura M; Ozaki S; Matsumura S; Matsuda S; Satoh H
    Nihon Yakurigaku Zasshi; 1984 Aug; 84(2):175-212. PubMed ID: 6149178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the muscle relaxation effects of ethyl loflazepate (CM6912) and evaluation as an anti-anxiety drug.
    Sakai Y; Namima M
    Jpn J Pharmacol; 1984 Nov; 36(3):319-28. PubMed ID: 6151605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of CN-100 (2-(10,11-dihydro-10-oxodibenzo [b,f] thiepin-2-yl) propionic acid) on cardiovascular and autonomic nervous function in the dog and guinea pig].
    Kushiku K; Abe M; Morishita H; Furukawa T
    Nihon Yakurigaku Zasshi; 1989 Nov; 94(5):299-307. PubMed ID: 2613109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.